Stock MRK MERCK & CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse
Other stock markets
 04:00:50 2024-05-15 pm EDT 		5-day change 1st Jan Change
131.7 USD +2.39% Intraday chart for Merck & Co., Inc. +1.68% +20.83%
May. 15 Merck to present new oncology data CF
May. 14 US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine RE

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Redburn Atlantic Adjusts Price Target on Merck to $148 From $142
MT
Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141
MT
Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128
MT
Guggenheim Adjusts Price Target on Merck to $146 From $144
MT
Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135
MT
Deutsche Bank Adjusts Price Target on Merck & Company to $140 From $135
MT
JPMorgan Chase Adjusts Price Target on Merck to $145 From $140
MT
Goldman Sachs Raises Price Target on Merck & Company to $144 From $139
MT
Leerink Partners Raises Price Target on Merck & Company to $136 From $132
MT
Truist Lifts Price Target on Merck to $143 From $142, Keeps Buy Rating
MT
Jefferies Adjusts Merck & Company Price Target to $150 From $145
MT
Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating
MT
BMO Capital Adjusts Price Target on Merck & Company to $148 From $132
MT
Leerink Partners Raises Merck's Price Target to $134 From $129
MT
Zacks Adjusts Price Target on Merck & Company to $132 From $128
MT
Berenberg Raises Price Target on Merck & Company to $143 From $140, Maintains Buy Rating
MT
Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating
MT
Wells Fargo Raises Price Target on Merck to $135 From $130, Maintains Equal-Weight Rating
MT
Societe Generale Downgrades Merck to Sell From Hold, Raises Price Target to $104 From $103
MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...
Our Logo
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck & Co., Inc.
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW